A Comprehensive Review of N-Heterocycles as Cytotoxic Agents

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Organic Chemistry

Background:

• The scientific community is investigating heterocycles and fused heterocycles for their impact on multi-drug resistance (MDR) in anticancer drugs.
• Developing effective cancer treatments with minimal side effects remains a significant challenge.
• Novel drug design is crucial to overcome cancer's complexity and limitations of current therapies.

Purpose of the Study:

• To review recent advancements in anticancer heterocyclic agents globally.
• To explore the structure-activity relationships (SAR) of promising anticancer molecules.
• To present structures and IC50 values of novel anticancer compounds against various human cancer cell lines.

Main Methods:

• Literature review of recent developments in anticancer heterocyclic agents.
• Analysis of structure-activity relationships (SAR) for identified compounds.
• Compilation of IC50 values for promising molecules against diverse cancer cell lines.

Main Results:

• Identification of promising heterocyclic scaffolds with potential anticancer activity.
• Correlation of specific structural features with observed anticancer efficacy.
• Presentation of detailed IC50 data for selected compounds against various human cancer cell lines.

Conclusions:

• Heterocyclic and fused heterocyclic compounds represent a vital area for developing novel anticancer agents.
• Understanding SAR is key to designing more potent and selective anticancer drugs.
• Continued research into novel heterocyclic structures is essential for advancing cancer therapy.